Diniz L. Marques
Recife, PE, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Multidimensional contributors to disease burden in axial spondyloarthritis: role of central sensitization, catastrophizing and sleep disturbance.
Journal: Advances in rheumatology (London, England)
Published: September 29, 2025
Correction: Brazilian recommendations for the management of tuberculosis infection in immune-mediated inflammatory diseases.
Journal: Advances in rheumatology (London, England)
Published: July 21, 2025
Reply to the letter on "Brazilian guidelines for the management of tuberculosis infection in immune-mediated inflammatory diseases: is retesting in latent tuberculosis screening appropriate and safe?"
Journal: Advances in rheumatology (London, England)
Published: July 17, 2025
Position statement of the Biotechnology Committee of the Brazilian Society of Rheumatology on the interchangeability of originator and biosimilar biologics in immune-mediated rheumatic diseases.
Journal: Advances in rheumatology (London, England)
Published: October 06, 2024
Brazilian recommendations for the management of tuberculosis infection in immune-mediated inflammatory diseases.
Journal: Advances in rheumatology (London, England)
Published: October 02, 2024
Socioeconomic factors and COVID-19 mortality in immune-mediated rheumatic diseases patients: regional analysis from Argentina, Mexico and Brazil.
Journal: Advances in rheumatology (London, England)
Published: May 02, 2024
To be or not to B27 positive: implications for the phenotypes of axial spondyloarthritis outcomes. Data from a large multiracial cohort from the Brazilian Registry of Spondyloarthritis.
Journal: Advances in rheumatology (London, England)
Published: March 21, 2024
Factors Associated With Mortality in Patients With Immune-Mediated Rheumatic Diseases and COVID-19 From Latin America: Data From Argentina, Mexico, and Brazil.
Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
Published: November 08, 2023
Synergism between chikungunya virus infection and rheumatoid arthritis on cytokine levels: Clinical implications?
Journal: Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]
Published: January 07, 2023
Treatment with biological therapy is associated with faster recovery and lower frequency of treatment switch among rheumatic patients with Chikungunya fever.
Journal: Advances in rheumatology (London, England)
Published: February 16, 2022
COVID-19 was not associated or trigger disease activity in spondylarthritis patients: ReumaCoV-Brasil cross-sectional data.
Journal: Advances in rheumatology (London, England)
Published: February 08, 2022
Chikungunya virus as a trigger for different renal disorders: an exploratory study.
Journal: Journal of nephrology
Published: October 19, 2021
Last Updated: 09/26/2026